공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 연속 혈당 모니터링 기기 시장 : 컴포넌트별(수신기, 센서, 송신기), 최종사용자별(재택 케어 진단, 병원) 시장 조사, 예측(-2025년), COVID-19의 누적 영향

Continuous Glucose Monitoring Device Market Research Report by Component, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1001095
페이지 정보 영문 181 Pages
가격
US $ 3,949 ₩ 4,523,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,669,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,105,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,396,000 PDF (Enterprise License) + Excel


세계의 연속 혈당 모니터링 기기 시장 : 컴포넌트별(수신기, 센서, 송신기), 최종사용자별(재택 케어 진단, 병원) 시장 조사, 예측(-2025년), COVID-19의 누적 영향 Continuous Glucose Monitoring Device Market Research Report by Component, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 181 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 연속 혈당 모니터링 기기 시장 규모는 2020년 34억 2,958만 달러에서 2025년 말까지 54억 8,469만 달러로 성장할 것으로 예상됩니다.

COVID-19는 거의 모든 업계에 영향을 미친 전례 없는 세계적인 공중위생상 긴급사태이기 때문에 예측기간 중 업계의 성장에 장기적인 영향을 미칠 것으로 예측됩니다. 우리가 진행중인 조사는 조사 프레임워크를 증폭하고, 기초가 되는 COVID-19의 문제와 향후 잠재적 방향을 확실히 포함시키고 있습니다. 조사는 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재라우팅, 현재 시장 힘의 역학 및 정부의 중요한 개입을 고려한 COVID-19에 관한 인사이트를 제공합니다. 갱신된 조사는 시장에 대한 COVID-19의 영향을 고려하고, 인사이트, 분석, 추정 및 예측을 제공합니다.

세계의 연속 혈당 모니터링 기기(Continuous Glucose Monitoring Device) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, COVID-19의 영향, 컴포넌트·최종사용자·지역별 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 커버리지
  • 조사 대상 연도
  • 통화와 가격
  • 언어
  • 제한
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 디자인
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 갱신
  • 조사 실행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 실행 : 조사 실시
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 주요 요약

  • 시장 전망
  • 컴포넌트 전망
  • 최종사용자 전망
  • 지역 전망
  • 경쟁사 전망

제4장 시장 개요

  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porters Five Forces 분석
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 고객의 협상력
    • 공급 기업의 협상력
    • 업계의 경쟁

제6장 컴포넌트별

  • 수신기
  • 센서
  • 송신기

제7장 최종사용자별

  • 재택 케어 진단
  • 병원

제8장 아메리카

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제10장 유럽, 중동 및 아프리카

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제11장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금 조달
    • 상, 표창, 확대

제12장 기업 유저빌리티 개요

  • Abbott Laboratories
  • Baxter International Inc
  • Bayer AG
  • Dexcom Inc.
  • Echo Therapeutics, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • GlySens Incorporated
  • Insulet Corporation
  • Johnson & Johnson Services Inc
  • Medtronic PLC
  • Medtrum Technologies, Inc
  • Menarini Diagnostics
  • Microchip Technology Inc
  • Micron Technology Inc.
  • Nemaura Medical, Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Senseonics Holdings
  • Tandem Diabetes Care
  • Texas Instruments Inc
  • Ypsomed AG

제13장 부록

  • 논의 가이드
  • 라이선스와 가격
KSM 21.04.29

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2020 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2026
  • FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2020 VS 2026 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2026
  • FIGURE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 24. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 26. ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. CANADA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. MEXICO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. CALIFORNIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. FLORIDA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. ILLINOIS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. NEW YORK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. OHIO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. PENNSYLVANIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. TEXAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 39. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 41. CHINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. INDIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. INDONESIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. JAPAN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. MALAYSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. PHILIPPINES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. THAILAND CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. NETHERLANDS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. QATAR CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 65. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. MEXICO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CALIFORNIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CALIFORNIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. FLORIDA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. FLORIDA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ILLINOIS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ILLINOIS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. NEW YORK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. NEW YORK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. OHIO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. OHIO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. PENNSYLVANIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. PENNSYLVANIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. TEXAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. TEXAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CHINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CHINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. INDIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. INDIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDONESIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDONESIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. JAPAN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. JAPAN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MALAYSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MALAYSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PHILIPPINES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PHILIPPINES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. THAILAND CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. THAILAND CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NETHERLANDS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NETHERLANDS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. QATAR CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. QATAR CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SCORES
  • TABLE 83. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: BUSINESS STRATEGY
  • TABLE 84. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: PRODUCT SATISFACTION
  • TABLE 85. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: RANKING
  • TABLE 86. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 87. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 88. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: MERGER & ACQUISITION
  • TABLE 89. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 90. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 91. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: INVESTMENT & FUNDING
  • TABLE 92. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 93. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: LICENSE & PRICING
  • TABLE 94. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: CONTACT DETAILS

The Global Continuous Glucose Monitoring Device Market size was estimated at USD 3,429.57 Million in 2020 and expected to reach USD 3,784.38 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.68% to reach USD 6,305.90 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Continuous Glucose Monitoring Device to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the Continuous Glucose Monitoring Device Market was studied across Receivers, Sensors, and Transmitters.

Based on End-User , the Continuous Glucose Monitoring Device Market was studied across Homecare diagnostics and Hospitals.

Based on Geography, the Continuous Glucose Monitoring Device Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Continuous Glucose Monitoring Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Continuous Glucose Monitoring Device Market, including Abbott Laboratories, Baxter International Inc, Bayer AG, Dexcom Inc., Echo Therapeutics, Inc., F. Hoffmann-La Roche AG, GE Healthcare, GlySens Incorporated, Insulet Corporation, Johnson & Johnson Services Inc, Medtronic PLC, Medtrum Technologies, Inc, Menarini Diagnostics, Microchip Technology Inc, Micron Technology Inc., Nemaura Medical, Inc., Novo Nordisk A/S, Pfizer Inc., Senseonics Holdings, Tandem Diabetes Care, Texas Instruments Inc, and Ypsomed AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Continuous Glucose Monitoring Device Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Glucose Monitoring Device Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Glucose Monitoring Device Market?
  • 4. What is the competitive strategic window for opportunities in the Global Continuous Glucose Monitoring Device Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Continuous Glucose Monitoring Device Market?
  • 6. What is the market share of the leading vendors in the Global Continuous Glucose Monitoring Device Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Continuous Glucose Monitoring Device Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Component Outlook
  • 3.4. End-User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of diabetes and cardiovascular diseases require regular and continuous monitoring for a lifetime
      • 5.1.1.2. Growing demand for home-based treatment and self-medication to manage irregular chronic and acute illnesses
      • 5.1.1.3. Rising demand for less invasive products
    • 5.1.2. Restraints
      • 5.1.2.1. Surge in the price of CGM devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and excessive research & development
      • 5.1.3.2. Developing awareness regarding the use of CGM devices in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of accuracy of CGM devices
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Continuous Glucose Monitoring Device Market, by Component

  • 6.1. Introduction
  • 6.2. Receivers
  • 6.3. Sensors
  • 6.4. Transmitters

7. Continuous Glucose Monitoring Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Homecare diagnostics
  • 7.3. Hospitals

8. Americas Continuous Glucose Monitoring Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Continuous Glucose Monitoring Device Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Continuous Glucose Monitoring Device Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Baxter International Inc
  • 12.3. Bayer AG
  • 12.4. Dexcom Inc.
  • 12.5. Echo Therapeutics, Inc.
  • 12.6. F. Hoffmann-La Roche AG
  • 12.7. GE Healthcare
  • 12.8. GlySens Incorporated
  • 12.9. Insulet Corporation
  • 12.10. Johnson & Johnson Services Inc
  • 12.11. Medtronic PLC
  • 12.12. Medtrum Technologies, Inc
  • 12.13. Menarini Diagnostics
  • 12.14. Microchip Technology Inc
  • 12.15. Micron Technology Inc.
  • 12.16. Nemaura Medical, Inc.
  • 12.17. Novo Nordisk A/S
  • 12.18. Pfizer Inc.
  • 12.19. Senseonics Holdings
  • 12.20. Tandem Diabetes Care
  • 12.21. Texas Instruments Inc
  • 12.22. Ypsomed AG

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details
Back to Top
전화 문의
F A Q